We recently published an article titled Jim Cramer Discusses These 10 Stocks & An Outfit Better Than DeepSeek. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands ...

In this piece, we will look at the stocks Jim Cramer recently discussed.

Bernstein SocGen Group has revised its price target for Merck (NYSE:MRK) shares, bringing it down to $95 from the previous $110 while maintaining a Market Perform rating. Analyst Courtney Breen cited ...

Humana forecast annual profit slightly below Wall Street estimates on Tuesday, signaling that costs from its ...

Investing.com -- 德国默克公司（Merck KGaA）表示，正在就潜在收购美国生物制药公司SpringWorks Therapeutics进行深入谈判。SpringWorks Therapeutics专注于罕见疾病和癌症治疗领域。 这家德国生命科学和化工公司表示，目前尚未达成具有法律约束力的协议，也不能保证最终一定会达成交易。

德国制药巨头默克公司（Merck KGaA）确认，正在就收购美国生物制药公司SpringWorks Therapeutics进行深入谈判，后者是一家专门研究罕见疾病和癌症的公司。 默克当地时间周一晚间表示，双方尚未达成具有法律约束力的协议，也不确定是否会达成任何交易。该公司 ...

Sonoco Products (NYSE:SON – Get Free Report) is expected to be releasing its earnings data after the market closes on Tuesday, February 18th. Analysts expect Sonoco Products to post earnings of $1.18 ...

Investment analysts at Wedbush cut their FY2025 earnings per share estimates for Advanced Micro Devices in a research report issued on Wednesday, February 5th. Wedbush analyst M. Bryson now expects ...

Die Merck KGaA befindet sich in fortgeschrittenen Verhandlungen zum Kauf des amerikanischen Krebsspezialisten SpringWorks ...

智通财经获悉，默克公司 (Merck KGaA)表示，收购美国癌症和罕见疾病制药公司SpringWorks Therapeutics ...

We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...

SpringWorks Therapeutics stock surged over Monday after a report from Reuters that German medical tech giant Merck KGaA could be close to acquiring the company.